, the exact molecular mechanisms and signaling pathways that explain why claudin proteins are so important

be used for diagnosis and prognosis, including the response of a particular patient to therapy

-tumor barrier (BTB), which limit the efficacy of systemic therapies. Recent advances in molecular biology

of the molecular genetic mechanisms of the pathogenesis of DM is of critical importance for the development of new

in the molecular mechanisms of liver cancer and examining its potential for clinical application. By exploring

Molecular genetic studies make it possible to determine associations of multifactorial diseases

in the pathogenesis of GBM, as well as therapies that target these pathways. Glioblastoma remains a diffi‑ cult

in the expression of miRNAs) and designing their targeted therapy using specific miRNAs as targets. This article

) and ischemic stroke (IS). Numerous studies have confirmed the importance of understanding the molecular

. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogeneity and resistance to therapy. Modern